Machine learning methods for predicting early recurrence in Ta stage bladder cancer and comparison with conventional
Ubeyd Sungur1, Alper Bitkin2, Mithat Ekşi2
1Department of Urology, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, University of Health Sciences, Istanbul, Türkiye - ubeydsungur@gmail.com.
Minerva Urology and Nephrology
|January 12, 2026
Summary
Machine learning models offer superior prediction accuracy for Ta bladder cancer recurrence compared to traditional methods. This study highlights ML
Area of Science:
- Urology
- Oncology
- Medical Informatics
Background:
- Predicting recurrence in Ta-stage bladder cancer is critical for patient management.
- Non-muscle invasive bladder cancers (NMIBC) require accurate prognostication for effective follow-up strategies.
- Early identification of recurrence risk in Ta bladder cancer is essential.
Purpose of the Study:
- To compare the predictive performance of machine learning (ML) models against conventional statistical methods.
- To evaluate the accuracy in predicting 2-year postoperative recurrence for Ta stage bladder cancer.
- To identify significant clinical and pathological factors associated with early recurrence.
Main Methods:
- Retrospective analysis of 184 patients with primary Ta bladder cancer between 2018-2021.
- Data included demographic, clinical, imaging, and pathological parameters.
- Prediction models were constructed using Cox-regression, random forest, logistic regression, and k-nearest neighbors (KNN) algorithms.
Main Results:
- Significant predictors for early recurrence included Body Mass Index, American Society of Anesthesiologists (ASA) score, and macroscopic hematuria.
- Conventional Cox-regression model yielded an Area Under the Curve (AUC) of 0.66.
- Machine learning models demonstrated superior performance: Random Forest (AUC=0.75), Logistic Regression (AUC=0.87), and KNN (AUC=0.74).
Conclusions:
- Machine learning models significantly outperform conventional statistical methods in predicting Ta bladder cancer recurrence.
- ML-based prediction tools can enhance the accuracy of recurrence risk assessment in NMIBC.
- The findings support the integration of ML into clinical decision-making for bladder cancer follow-up.
More Related Videos
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
8.6K
07:15Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
Published on: August 16, 2020
7.4K
